MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 10-23-2025
Medpace Holdings ROE Ratio 2011-2025 | MEDP
Annual ROE Ratio Medpace Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 48.98 | 50.6 | 63.5 | 19.08 | 18.04 | 13.83 | 12.41 | 7.77 | 2.2 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 63.5 | 2.2 | 26.27 |
Quarterly ROE Ratio Medpace Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120.46 | 93.55 | 52.75 | 37.79 | 52.77 | 56.81 | 60.86 | 51.59 | 70.46 | 74.35 | 76.16 | 46.43 | 51.84 | 38.38 | 25.64 | 15.14 | 20.28 | 20.02 | 18.32 | 11.73 | 15.83 | 13.99 | 14.78 | 13.83 | 13.53 | 13.5 | 12.53 | 12.35 | 10.77 | 9.45 | 8.53 | 7.74 | 5.52 | 4.4 | 3.31 | 2.2 | 0.13 | -0.73 | -1.54 | -2.11 | -0.03 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 120.46 | -2.11 | 28.13 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aspira Women's Health
AWH
|
-403.65 | - | -6.19 % | $ 10.5 M |  USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M |  Israel |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
DexCom
DXCM
|
26.18 | $ 64.79 | 2.0 % | $ 25 B | USA |
 |
Brainsway Ltd.
BWAY
|
-27.43 | $ 17.23 | 1.5 % | $ 99.4 M | Israel |
 |
Burning Rock Biotech Limited
BNR
|
-43.17 | $ 21.15 | 11.37 % | $ 233 M |  China |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
-35.99 | $ 101.24 | 0.04 % | $ 18.8 B | USA |
 |
Biomerica
BMRA
|
-121.14 | $ 2.31 | 2.01 % | $ 5.31 M | USA |
 |
BioNano Genomics
BNGO
|
-316.66 | $ 1.69 | -1.74 % | $ 2.15 M | USA |
 |
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
-41.08 | $ 0.36 | -0.39 % | $ 10.6 M | USA |
 |
Guardant Health
GH
|
312.48 | $ 104.81 | -0.39 % | $ 12.9 B | USA |
 |
Celcuity
CELC
|
-96.68 | $ 98.24 | -0.25 % | $ 3.88 B | USA |
 |
DarioHealth Corp.
DRIO
|
-102.21 | $ 11.75 | -0.47 % | $ 333 M | Israel |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
ICON Public Limited Company
ICLR
|
8.31 | $ 185.09 | 2.99 % | $ 15.3 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
55.65 | $ 733.11 | 0.57 % | $ 60.5 B | USA |
 |
Danaher Corporation
DHR
|
7.87 | $ 228.08 | 1.74 % | $ 167 B | USA |
 |
Illumina
ILMN
|
-51.54 | $ 128.88 | 0.12 % | $ 20.5 B | USA |
 |
Anixa Biosciences
ANIX
|
-62.78 | $ 4.25 | -3.41 % | $ 136 K | USA |
 |
Laboratory Corporation of America Holdings
LH
|
9.26 | $ 267.33 | -0.14 % | $ 22.4 B | USA |
 |
Lantheus Holdings
LNTH
|
28.72 | $ 58.6 | -0.81 % | $ 4.06 B | USA |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | USA |
 |
Mettler-Toledo International
MTD
|
-680.23 | $ 1 457.09 | -0.75 % | $ 30.9 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
-18.16 | $ 7.06 | -0.03 % | $ 640 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-449.46 | $ 5.81 | -1.43 % | $ 3.12 M | USA |
 |
NeoGenomics
NEO
|
-8.72 | $ 12.02 | -0.04 % | $ 1.52 B | USA |
 |
Neogen Corporation
NEOG
|
-52.72 | $ 5.91 | -0.25 % | $ 1.28 B | USA |
|
Biodesix
BDSX
|
-205.65 | $ 7.79 | - | $ 1.01 B | USA |
 |
National Research Corporation
NRC
|
63.26 | $ 16.27 | -3.1 % | $ 399 M | USA |
 |
Natera
NTRA
|
-77.62 | $ 237.72 | 1.48 % | $ 23.4 B | USA |
 |
Invitae Corporation
NVTA
|
-98.02 | - | - | $ 21.2 M | USA |
 |
Castle Biosciences
CSTL
|
4.0 | $ 39.24 | 0.31 % | $ 1.09 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
12.85 | $ 184.06 | 0.16 % | $ 20.4 B | USA |
 |
Fulgent Genetics
FLGT
|
-3.77 | $ 28.38 | -0.49 % | $ 858 M | USA |
 |
Organovo Holdings
ONVO
|
-23.71 | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
162.49 | - | -16.95 % | $ 1.54 M | USA |
 |
Pacific Biosciences of California
PACB
|
-43.74 | $ 2.33 | 4.69 % | $ 591 M | USA |
 |
PerkinElmer
PKI
|
3.53 | - | -0.91 % | $ 14.7 B | USA |
 |
Psychemedics Corporation
PMD
|
-62.26 | - | -1.84 % | $ 15.3 M | USA |
 |
Precipio
PRPO
|
-40.56 | $ 24.56 | 8.81 % | $ 31.9 M | USA |
 |
Personalis
PSNL
|
-40.05 | $ 10.09 | 4.18 % | $ 598 M | USA |
 |
RadNet
RDNT
|
0.31 | $ 79.11 | -1.13 % | $ 5.78 B | USA |
|
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | China |